VA
ACIU icon

Verdad Advisers’s AC Immune ACIU Stock Holding History

Verdad Advisers’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.8K Buy
+16,300
New +$44.9K 0.04% 202

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Verdad Advisers's ACIU Position: Q2 2026 in Review

Verdad Advisers opened a new position in AC Immune (ACIU) in Q2 2026: 16,300 shares worth $38.8K. The stake represents 0.04% of the portfolio and ranks #202 among its holdings.

43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Verdad Advisers held 16,300 shares of AC Immune worth $38.8K as of Q2 2026.
  • AC Immune was a new Verdad Advisers position in Q2 2026.
  • AC Immune made up 0.04% of Verdad Advisers's portfolio in Q2 2026, its #202 holding.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.